5.2 Hemostasis Methods & Vascular Closure Devices

Key Takeaways

  • Before manual sheath removal, verify the arterial location, anticoagulant exposure and applicable ACT or timing requirement. Compress the arteriotomy and monitor for recurrent bleeding and changes in limb perfusion.

  • Use patent radial hemostasis to control bleeding while maintaining radial flow. A pulsatile digital waveform during brief ulnar compression provides evidence of continued radial flow.

  • Angio-Seal uses an anchor and collagen, ProStyle uses sutures, StarClose uses an external clip, and Mynx Control uses extravascular hydrogel.

  • The Angio-Seal VIP instructions describe a proximal reaccess option within 90 days under specified conditions. Use current labeling and reassess the access anatomy.

  • Check the vessel and access location using suitable imaging. Vessel caliber, wall disease, puncture location and sheath size must meet the criteria for the selected device.

Last updated: November 2026

5.2 Hemostasis Methods & Vascular Closure Devices

Clinical Core: Achieve hemostasis while monitoring for bleeding and preserving distal perfusion. The access site, anticoagulant exposure and actual sheath size guide the choice of compression or an implanted closure device. Verify anatomical eligibility and use the instructions for the device and model selected.


Manual Femoral Compression Protocols

Sheath Removal and the Activated Clotting Time

Before removing a femoral arterial sheath for manual compression, verify the order, recent anticoagulants, sheath size and access location. Check the puncture site, distal pulses and vital signs. An activated clotting time (ACT) can assess residual procedural unfractionated heparin (UFH) effect. For example, a U.S. cardiac catheterization laboratory protocol allows routine manual sheath removal once ACT is below 180 seconds. Follow the approved protocol for the case. The same ACT threshold cannot establish the safety of removal after every anticoagulant or fibrinolytic regimen. The prescriber determines whether reversal is indicated.

Locating the Arteriotomy and Maintaining Hemostasis

The arterial wall opening can lie proximal to the skin opening because the needle tract angles through tissue. Identify the artery and target pressure at the arteriotomy. Compression over the skin opening alone can leave the deeper vessel opening bleeding into tissue.

  1. At removal: Apply controlled pressure over the arteriotomy as the sheath is withdrawn. Monitor the puncture site for bleeding and hematoma, and compare distal perfusion with baseline.
  2. During compression: Use enough pressure and time to achieve hemostasis. Duration depends on the arteriotomy, sheath size, coagulation status and response to compression. If bleeding continues or a hematoma enlarges, maintain appropriate pressure and alert the clinical team.
  3. During recovery: Check vital signs, the puncture site and the limb. Follow orders on leg position, activity and ambulation. A stable site before ambulation can still rebleed with movement. Check the site again after activity.

Worked handoff. If the skin is dry but the groin becomes firmer or expands after sheath removal, report the change and check vital signs and distal perfusion. A dry puncture dressing cannot verify hemostasis at the arterial wall.


Mechanical Compression Aids: FemoStop & C-Clamp

A mechanical aid holds external pressure over the vessel. The FemoStop Gold has a belt, arch and transparent pneumatic dome with a manometer. Position and adjust it using the device instructions. The initial hemostatic pressure is followed by a reduction to the pressure that maintains hemostasis and restores limb perfusion. Check the site and distal pulses throughout use. Mechanical clamps can also maintain localized pressure, but the team still needs to reassess for bleeding, hematoma, excessive compression or a change in limb perfusion.


Radial Artery Hemostasis: The Patent Hemostasis Protocol

A pneumatic radial band, such as the TR Band, compresses the access site while the team monitors the visible puncture. Patent hemostasis combines two observations: the site is dry, and flow continues through the radial artery beneath the band. The randomized PROPHET study found less radial artery occlusion with documented patent hemostasis than with traditional compression after transradial coronary catheterization. Radial occlusion may be clinically silent when ulnar collateral flow is adequate.

To assess patent hemostasis, place a plethysmography sensor on a finger of the treated hand. Briefly compress the ulnar artery with the band in place. A persisting pulsatile signal supports flow through the radial artery. If the trace disappears, tell the operator or responsible clinician and reassess band pressure, sensor placement and perfusion. Adjust band pressure only within the approved instructions and protocol while observing for renewed bleeding. Use the model-specific inflation and deflation instructions. Anticoagulant exposure, site size and bleeding can affect the removal schedule. Check perfusion and the puncture site after band removal.


Vascular Closure Devices (VCDs): Classification & Mechanisms

Implant-based closure devices can shorten time to hemostasis or ambulation in selected access sites. Each device interacts differently with the vessel wall and tract. Group devices by what actually provides the closure, and verify arterial or venous indication and sheath compatibility for the exact product.

Example deviceClosure mechanismSelected U.S. labeling points
Angio-Seal VIPAn absorbable anchor inside the artery is connected to an external collagen sponge by an absorbable suture. The anchor and sponge oppose each other across the arterial wall.An arterial closure product with 6 Fr and 8 Fr versions. The instructions caution against use in a femoral artery smaller than 4 mm and describe a separate qualified reaccess approach within 90 days.
Perclose ProStyleA suture draws the edges of the access opening together.Common femoral arterial 5–21 Fr and common femoral venous 5–24 Fr sheath sizes. For arterial sheaths above 8 Fr or venous sheaths above 14 Fr, use at least two devices and place the sutures by the pre-close technique.
StarClose SEAn extravascular nitinol clip brings together the edges of the arteriotomy.Common femoral arterial use with 5 or 6 Fr procedural sheaths under the specified conditions. The clip remains outside the vessel lumen.
Mynx ControlA temporary intravascular balloon positions an extravascular polyethylene glycol (PEG) hydrogel sealant. The balloon is removed.The arterial model is sized for 5 or 6/7 Fr sheaths. A separate MYNX CONTROL Venous 6–12 Fr model has its own labeling.

Planning Reaccess and Large-Bore Closure

The Angio-Seal VIP IFU describes absorbable implant components and states that if reaccess in the same area is needed within 90 days, a site 1 cm proximal to the previous access site can be considered under the stated conditions. This is still a new puncture that must be verified as anatomically suitable. Abbott's ProStyle labeling specifies no device-imposed reaccess restriction. The operator still assesses the site and the patient's clinical status. A closure material's absorption time alone does not establish when or where a new puncture can be safely made.

For large-bore access, pre-close places sutures in the vessel wall before upsizing the sheath. The operator secures the sutures at the end of the procedure as the large sheath is removed. A 20 Fr femoral arterial sheath, for example, is within the stated ProStyle arterial range and requires at least two devices and pre-close. A 24 Fr femoral arterial sheath is outside that range. The 24 Fr figure applies to labeled femoral venous use.


Angiographic Prerequisites & Contraindications for VCD Deployment

Review imaging and the planned device's instructions before deployment. Select a view that shows the actual puncture and separates the superficial and deep femoral branches. An ipsilateral anterior oblique view often helps display the bifurcation. The required image and angle depend on the projection, anatomy and closure device. Some labels call for an angiogram before deployment. The U.S. ProStyle instructions specify femoral angiography to assess the access site for size, calcium, tortuosity and vessel wall disease and to verify anterior-wall entry.

Check the access level, vessel diameter, wall calcification or plaque, arterial injury and the route of the puncture tract. A puncture above the inguinal ligament or in a branch may be outside the labeled conditions for a CFA closure device. Review warnings as well as formal contraindications. If the device is unsuitable, alert the operator for another hemostasis plan and verify the selected plan. After any closure method, reassess the puncture site and distal perfusion.

Loading diagram...
Hemostasis Selection and VCD Pre-Deployment Algorithm
Test Your Knowledge

After a femoral arterial intervention using UFH, the lab protocol permits routine sheath removal for manual compression at an ACT below 180 seconds. The current ACT is 196 seconds and the site is stable. What is the appropriate routine next step?

A

Remove the sheath because the ACT is below 200 seconds

B

Remove the sheath and use the observed puncture site to decide whether to check ACT again

C

Give reversal medication without an order so the sheath can be removed immediately

D

Keep the sheath in place, notify the responsible clinician as required and reassess the ACT under the lab protocol

Test Your Knowledge

Repeat femoral arterial access is required six weeks after closure with Angio-Seal VIP. Which statement correctly describes the early reaccess option in the U.S. instructions under suitable anatomical conditions?

A

Advance the access needle through the original implant because the anchor remains entirely outside the artery

B

Reenter 1 cm distal to the previous access site because the downstream path is always clear of the implant

C

Consider reentry 1 cm proximal to the previous access site after verifying that the new site is suitable

D

Wait for the 90-day interval to pass before considering any access in the same femoral artery

Test Your Knowledge

The operator is considering ProStyle for a common femoral arterial access after pelvic embolization. The AP image obscures the femoral bifurcation. Which imaging plan best supports the closure decision?

A

Accept the AP position if the skin puncture overlies the femoral head

B

Obtain an angiographic view that separates the branches and shows vessel caliber, wall disease and the actual anterior-wall puncture relative to the bifurcation

C

Obtain a view limited to the external iliac artery and estimate the lower branch locations from the skin entry

D

Use a magnified image of the skin mark to estimate the vessel diameter and closure site

Sections you finish are checked off in the contents.